

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.57575543 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.57575543 |
| 3 | sodium ion export (GO:0071436) | 5.46702149 |
| 4 | positive regulation of synapse maturation (GO:0090129) | 5.41955202 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.35141940 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.35141940 |
| 7 | cellular potassium ion homeostasis (GO:0030007) | 5.16987595 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.03066737 |
| 9 | regulation of synaptic vesicle transport (GO:1902803) | 4.94261360 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.88399809 |
| 11 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.73962979 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.53904240 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.51997170 |
| 14 | synaptic vesicle endocytosis (GO:0048488) | 4.50624080 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.49583607 |
| 16 | urea metabolic process (GO:0019627) | 4.43470330 |
| 17 | urea cycle (GO:0000050) | 4.43470330 |
| 18 | neuronal ion channel clustering (GO:0045161) | 4.37001079 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 4.35028036 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 4.33173120 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 4.31130609 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 4.31130609 |
| 23 | tryptophan catabolic process (GO:0006569) | 4.31130609 |
| 24 | cerebellar granule cell differentiation (GO:0021707) | 4.23148606 |
| 25 | amino acid import (GO:0043090) | 4.16525003 |
| 26 | exploration behavior (GO:0035640) | 4.14206621 |
| 27 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.12467986 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.07153001 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.06905481 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 4.06876923 |
| 31 | neurotransmitter transport (GO:0006836) | 4.06230814 |
| 32 | glyoxylate metabolic process (GO:0046487) | 4.03181302 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.02754346 |
| 34 | tryptophan metabolic process (GO:0006568) | 3.99609262 |
| 35 | regulation of ARF protein signal transduction (GO:0032012) | 3.99577461 |
| 36 | cell migration in hindbrain (GO:0021535) | 3.93422277 |
| 37 | regulation of synapse maturation (GO:0090128) | 3.92022436 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 3.91608612 |
| 39 | glutamate metabolic process (GO:0006536) | 3.91416126 |
| 40 | complement activation, alternative pathway (GO:0006957) | 3.89576684 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.89361051 |
| 42 | regulation of protein activation cascade (GO:2000257) | 3.86513139 |
| 43 | L-amino acid import (GO:0043092) | 3.84999175 |
| 44 | protein localization to synapse (GO:0035418) | 3.83940908 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.83850369 |
| 46 | regulation of fibrinolysis (GO:0051917) | 3.83627119 |
| 47 | regulation of synaptic plasticity (GO:0048167) | 3.83313874 |
| 48 | bile acid metabolic process (GO:0008206) | 3.83285148 |
| 49 | cysteine metabolic process (GO:0006534) | 3.82257459 |
| 50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.82091128 |
| 51 | protein carboxylation (GO:0018214) | 3.82091128 |
| 52 | lysine catabolic process (GO:0006554) | 3.81019268 |
| 53 | lysine metabolic process (GO:0006553) | 3.81019268 |
| 54 | establishment of mitochondrion localization (GO:0051654) | 3.80655541 |
| 55 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.79689541 |
| 56 | reverse cholesterol transport (GO:0043691) | 3.78978066 |
| 57 | regulation of cholesterol esterification (GO:0010872) | 3.75826444 |
| 58 | dendritic spine organization (GO:0097061) | 3.75484535 |
| 59 | neuromuscular process controlling balance (GO:0050885) | 3.73602415 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 3.73134512 |
| 61 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.73017230 |
| 62 | macromolecular complex remodeling (GO:0034367) | 3.70592343 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.70592343 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 3.70592343 |
| 65 | positive regulation of membrane potential (GO:0045838) | 3.70480343 |
| 66 | serine family amino acid catabolic process (GO:0009071) | 3.69236857 |
| 67 | synaptic vesicle maturation (GO:0016188) | 3.69034767 |
| 68 | positive regulation of dendritic spine development (GO:0060999) | 3.68966427 |
| 69 | protein retention in ER lumen (GO:0006621) | 3.67907210 |
| 70 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.66455966 |
| 71 | regulation of neurotransmitter levels (GO:0001505) | 3.64672609 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 3.64137394 |
| 73 | negative regulation of sterol transport (GO:0032372) | 3.64137394 |
| 74 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.59828172 |
| 75 | postsynaptic membrane organization (GO:0001941) | 3.58750889 |
| 76 | regulation of complement activation (GO:0030449) | 3.57491804 |
| 77 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.56429176 |
| 78 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.56426302 |
| 79 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.55452808 |
| 80 | mitochondrion transport along microtubule (GO:0047497) | 3.55320282 |
| 81 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.55320282 |
| 82 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.54193833 |
| 83 | phospholipid efflux (GO:0033700) | 3.54188452 |
| 84 | triglyceride homeostasis (GO:0070328) | 3.54153626 |
| 85 | acylglycerol homeostasis (GO:0055090) | 3.54153626 |
| 86 | alpha-amino acid catabolic process (GO:1901606) | 3.52769903 |
| 87 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.50564395 |
| 88 | synaptic transmission, glutamatergic (GO:0035249) | 3.50017213 |
| 89 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.46654815 |
| 90 | locomotory exploration behavior (GO:0035641) | 3.46475177 |
| 91 | aromatic amino acid family metabolic process (GO:0009072) | 3.46243399 |
| 92 | dendritic spine morphogenesis (GO:0060997) | 3.44188955 |
| 93 | positive regulation of neurotransmitter transport (GO:0051590) | 3.43211158 |
| 94 | coenzyme catabolic process (GO:0009109) | 3.41342052 |
| 95 | glutamate secretion (GO:0014047) | 3.39721668 |
| 96 | regulation of vesicle fusion (GO:0031338) | 3.38981539 |
| 97 | homocysteine metabolic process (GO:0050667) | 3.37431274 |
| 98 | tyrosine metabolic process (GO:0006570) | 3.37187873 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 3.36533490 |
| 100 | cholesterol efflux (GO:0033344) | 3.34989307 |
| 101 | ketone body metabolic process (GO:1902224) | 3.34697663 |
| 102 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.34669986 |
| 103 | amino-acid betaine metabolic process (GO:0006577) | 3.33195735 |
| 104 | drug catabolic process (GO:0042737) | 3.33038977 |
| 105 | potassium ion homeostasis (GO:0055075) | 3.32865888 |
| 106 | regulation of neurotransmitter secretion (GO:0046928) | 3.32145447 |
| 107 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.31968138 |
| 108 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31699025 |
| 109 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.31235273 |
| 110 | cellular modified amino acid catabolic process (GO:0042219) | 3.29785215 |
| 111 | plasma lipoprotein particle clearance (GO:0034381) | 3.28962470 |
| 112 | cellular amino acid catabolic process (GO:0009063) | 3.28496392 |
| 113 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.26241783 |
| 114 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.26207879 |
| 115 | cell communication by electrical coupling (GO:0010644) | 3.26024490 |
| 116 | gamma-aminobutyric acid transport (GO:0015812) | 3.24610190 |
| 117 | neuron cell-cell adhesion (GO:0007158) | 3.22270091 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.21737658 |
| 119 | nucleobase catabolic process (GO:0046113) | 3.18955606 |
| 120 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.18564780 |
| 121 | cerebellar Purkinje cell layer development (GO:0021680) | 3.17828537 |
| 122 | long-term memory (GO:0007616) | 3.16172064 |
| 123 | neuronal action potential propagation (GO:0019227) | 3.12926997 |
| 124 | arginine metabolic process (GO:0006525) | 3.11441072 |
| 125 | bile acid and bile salt transport (GO:0015721) | 3.08677390 |
| 126 | regulation of postsynaptic membrane potential (GO:0060078) | 3.08609262 |
| 127 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.06373337 |
| 128 | aspartate family amino acid catabolic process (GO:0009068) | 3.05065375 |
| 129 | dicarboxylic acid catabolic process (GO:0043649) | 3.04348744 |
| 130 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.03952385 |
| 131 | vocalization behavior (GO:0071625) | 3.03775728 |
| 132 | synaptic vesicle transport (GO:0048489) | 3.03293230 |
| 133 | establishment of synaptic vesicle localization (GO:0097480) | 3.03293230 |
| 134 | central nervous system myelination (GO:0022010) | 3.03291933 |
| 135 | axon ensheathment in central nervous system (GO:0032291) | 3.03291933 |
| 136 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.03084678 |
| 137 | 2-oxoglutarate metabolic process (GO:0006103) | 3.01843642 |
| 138 | exogenous drug catabolic process (GO:0042738) | 3.01266155 |
| 139 | regulation of bile acid biosynthetic process (GO:0070857) | 3.01081164 |
| 140 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.00876597 |
| 141 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00109250 |
| 142 | * dicarboxylic acid transport (GO:0006835) | 2.98650964 |
| 143 | synaptic vesicle exocytosis (GO:0016079) | 2.98425191 |
| 144 | neuron-neuron synaptic transmission (GO:0007270) | 2.97772211 |
| 145 | proline biosynthetic process (GO:0006561) | 2.96449252 |
| 146 | neurotransmitter secretion (GO:0007269) | 2.96309628 |
| 147 | plasma lipoprotein particle assembly (GO:0034377) | 2.96059382 |
| 148 | indolalkylamine metabolic process (GO:0006586) | 2.95729610 |
| 149 | negative regulation of microtubule polymerization (GO:0031115) | 2.93119105 |
| 150 | low-density lipoprotein particle remodeling (GO:0034374) | 2.92996155 |
| 151 | phospholipid homeostasis (GO:0055091) | 2.91594751 |
| 152 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.90430646 |
| 153 | benzene-containing compound metabolic process (GO:0042537) | 2.89725411 |
| 154 | negative regulation of lipase activity (GO:0060192) | 2.89001138 |
| 155 | acetyl-CoA metabolic process (GO:0006084) | 2.87922830 |
| 156 | imidazole-containing compound metabolic process (GO:0052803) | 2.87698369 |
| 157 | regulation of neurotransmitter transport (GO:0051588) | 2.86137941 |
| 158 | mating behavior (GO:0007617) | 2.85398341 |
| 159 | glutamate receptor signaling pathway (GO:0007215) | 2.85147463 |
| 160 | neuromuscular process controlling posture (GO:0050884) | 2.84945998 |
| 161 | regulation of synaptic transmission (GO:0050804) | 2.83820324 |
| 162 | alanine transport (GO:0032328) | 2.82557499 |
| 163 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.79894399 |
| 164 | cytolysis (GO:0019835) | 2.79599260 |
| 165 | vesicle docking involved in exocytosis (GO:0006904) | 2.78852487 |
| 166 | short-chain fatty acid metabolic process (GO:0046459) | 2.78417453 |
| 167 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.78372508 |
| 168 | organic acid catabolic process (GO:0016054) | 2.77374473 |
| 169 | carboxylic acid catabolic process (GO:0046395) | 2.77374473 |
| 170 | regulation of ARF GTPase activity (GO:0032312) | 2.76698566 |
| 171 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.75711424 |
| 172 | activation of protein kinase A activity (GO:0034199) | 2.75378701 |
| 173 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.74973021 |
| 174 | glycine metabolic process (GO:0006544) | 2.74867571 |
| 175 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.74684246 |
| 176 | ethanol oxidation (GO:0006069) | 2.73556823 |
| 177 | auditory behavior (GO:0031223) | 2.72177509 |
| 178 | positive regulation of dendrite development (GO:1900006) | 2.72003024 |
| 179 | regulation of dendrite morphogenesis (GO:0048814) | 2.70091357 |
| 180 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.69950667 |
| 181 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.69935334 |
| 182 | activation of Rac GTPase activity (GO:0032863) | 2.65716473 |
| 183 | neuromuscular synaptic transmission (GO:0007274) | 2.65710274 |
| 184 | neuromuscular process (GO:0050905) | 2.65086403 |
| 185 | regulation of dendritic spine development (GO:0060998) | 2.65017767 |
| 186 | potassium ion import (GO:0010107) | 2.64410594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.23015632 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.10085177 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.24732756 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.94556368 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.61197820 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.23182946 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.19114959 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.13013207 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.93360104 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.83055799 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.36190564 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.15863202 |
| 13 | * P68_20966046_ChIP-Seq_HELA_Human | 2.14538981 |
| 14 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.13899711 |
| 15 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.05476386 |
| 16 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.02205233 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.00484175 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.98632466 |
| 19 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95050579 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.94950613 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88600092 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87739791 |
| 23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87614141 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86084148 |
| 25 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.85467412 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.80473452 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79750358 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79278276 |
| 29 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78216905 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78203946 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77585351 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.75640843 |
| 33 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72845482 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72472498 |
| 35 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.70849978 |
| 36 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68827772 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66751739 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62333232 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62333232 |
| 40 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.61050697 |
| 41 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.60324344 |
| 42 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.59637913 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.59378389 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.54383666 |
| 45 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.54323305 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53619935 |
| 47 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.53223708 |
| 48 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.51076320 |
| 49 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51024189 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50548465 |
| 51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.48799049 |
| 52 | * MYC_22102868_ChIP-Seq_BL_Human | 1.48311921 |
| 53 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.47770793 |
| 54 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46588188 |
| 55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45136926 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43419411 |
| 57 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.42606063 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.40601244 |
| 59 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.37393489 |
| 60 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37273132 |
| 61 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36834216 |
| 62 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.36578402 |
| 63 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36065535 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34237103 |
| 65 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.34191126 |
| 66 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.31760084 |
| 67 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.31511366 |
| 68 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.29673623 |
| 69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29345280 |
| 70 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.24116271 |
| 71 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.23932512 |
| 72 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.23754546 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22987378 |
| 74 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.22468372 |
| 75 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22416322 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20012500 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.19939277 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19724554 |
| 79 | SA1_27219007_Chip-Seq_Bcells_Human | 1.19233874 |
| 80 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18681118 |
| 81 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.17824686 |
| 82 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.17471309 |
| 83 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14689872 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13834612 |
| 85 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13778779 |
| 86 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.12520432 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12089555 |
| 88 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.11856140 |
| 89 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.11712495 |
| 90 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.10914714 |
| 91 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.10150347 |
| 92 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.09945346 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09040750 |
| 94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08146349 |
| 95 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08046762 |
| 96 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.06978096 |
| 97 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06959560 |
| 98 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05083463 |
| 99 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02787975 |
| 100 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02578127 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02526161 |
| 102 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02108956 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01838137 |
| 104 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.01581773 |
| 105 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01580996 |
| 106 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99035661 |
| 107 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98821181 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98668324 |
| 109 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97919911 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97844907 |
| 111 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96673786 |
| 112 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94853326 |
| 113 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92583080 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90447447 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86650105 |
| 116 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85976585 |
| 117 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.85895980 |
| 118 | AR_19668381_ChIP-Seq_PC3_Human | 0.85534008 |
| 119 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82751627 |
| 120 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82002484 |
| 121 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.80770909 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79342140 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78660373 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78347447 |
| 125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.78105437 |
| 126 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77954512 |
| 127 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.77462037 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.74993106 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74864661 |
| 130 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.72415427 |
| 131 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.72361551 |
| 132 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.71917670 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68989611 |
| 134 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.68683324 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68105282 |
| 136 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.67076253 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67059814 |
| 138 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.66769375 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.65858515 |
| 140 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65524302 |
| 141 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.64503438 |
| 142 | AR_25329375_ChIP-Seq_VCAP_Human | 0.64335925 |
| 143 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63676936 |
| 144 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.63042553 |
| 145 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.62455682 |
| 146 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.62226591 |
| 147 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.61489083 |
| 148 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.61466606 |
| 149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.61389163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.10799360 |
| 2 | MP0005360_urolithiasis | 5.83231436 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.88010090 |
| 4 | MP0005365_abnormal_bile_salt | 4.68828647 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 4.22329158 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.88390823 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.09241583 |
| 8 | MP0003252_abnormal_bile_duct | 2.91374849 |
| 9 | MP0009840_abnormal_foam_cell | 2.64677726 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.39677336 |
| 11 | MP0005083_abnormal_biliary_tract | 2.35560376 |
| 12 | MP0002822_catalepsy | 2.30004280 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.20640281 |
| 14 | MP0005332_abnormal_amino_acid | 2.11638028 |
| 15 | MP0003329_amyloid_beta_deposits | 2.11151212 |
| 16 | MP0004270_analgesia | 2.07638964 |
| 17 | MP0003195_calcinosis | 2.00395033 |
| 18 | MP0003123_paternal_imprinting | 1.98669681 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.94054907 |
| 20 | MP0002063_abnormal_learning/memory/cond | 1.92204069 |
| 21 | MP0009745_abnormal_behavioral_response | 1.89423922 |
| 22 | MP0003880_abnormal_central_pattern | 1.88025799 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.84820001 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.82546644 |
| 25 | MP0002064_seizures | 1.78988625 |
| 26 | MP0000604_amyloidosis | 1.74653861 |
| 27 | MP0001348_abnormal_lacrimal_gland | 1.72361656 |
| 28 | MP0000778_abnormal_nervous_system | 1.60835028 |
| 29 | MP0009046_muscle_twitch | 1.58798404 |
| 30 | MP0000609_abnormal_liver_physiology | 1.54536930 |
| 31 | MP0001968_abnormal_touch/_nociception | 1.53738436 |
| 32 | MP0002249_abnormal_larynx_morphology | 1.53158332 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49628243 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.48407940 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.44775595 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.44130851 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.41734485 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.41534845 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.39374290 |
| 40 | MP0003868_abnormal_feces_composition | 1.38342898 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.37859309 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.37454723 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.34672141 |
| 44 | MP0004858_abnormal_nervous_system | 1.34354656 |
| 45 | MP0004130_abnormal_muscle_cell | 1.33972755 |
| 46 | MP0005535_abnormal_body_temperature | 1.31678220 |
| 47 | MP0002272_abnormal_nervous_system | 1.25679425 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.25519379 |
| 49 | MP0005409_darkened_coat_color | 1.25351130 |
| 50 | MP0001905_abnormal_dopamine_level | 1.23527082 |
| 51 | MP0000566_synostosis | 1.23268979 |
| 52 | MP0001188_hyperpigmentation | 1.23253598 |
| 53 | MP0001346_abnormal_lacrimal_gland | 1.22336195 |
| 54 | MP0002152_abnormal_brain_morphology | 1.20961485 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.19373929 |
| 56 | MP0001486_abnormal_startle_reflex | 1.18430923 |
| 57 | MP0003634_abnormal_glial_cell | 1.16936116 |
| 58 | MP0003122_maternal_imprinting | 1.16211489 |
| 59 | MP0003075_altered_response_to | 1.14348703 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.12934902 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.12826595 |
| 62 | MP0002735_abnormal_chemical_nociception | 1.12599912 |
| 63 | MP0002736_abnormal_nociception_after | 1.11246017 |
| 64 | MP0003879_abnormal_hair_cell | 1.09547833 |
| 65 | MP0002733_abnormal_thermal_nociception | 1.09494192 |
| 66 | MP0000920_abnormal_myelination | 1.08661216 |
| 67 | MP0000751_myopathy | 1.06784780 |
| 68 | MP0001764_abnormal_homeostasis | 1.06666796 |
| 69 | MP0003633_abnormal_nervous_system | 1.04893750 |
| 70 | MP0003690_abnormal_glial_cell | 1.04218821 |
| 71 | MP0008874_decreased_physiological_sensi | 1.03606687 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.02445502 |
| 73 | MP0001849_ear_inflammation | 1.02430698 |
| 74 | MP0008872_abnormal_physiological_respon | 1.01881899 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.00562434 |
| 76 | MP0008569_lethality_at_weaning | 1.00179443 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.99821364 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 0.97434233 |
| 79 | MP0001529_abnormal_vocalization | 0.95726997 |
| 80 | MP0004811_abnormal_neuron_physiology | 0.95095249 |
| 81 | MP0005448_abnormal_energy_balance | 0.94752446 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.93248170 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.92736009 |
| 84 | MP0005394_taste/olfaction_phenotype | 0.91006532 |
| 85 | MP0005499_abnormal_olfactory_system | 0.91006532 |
| 86 | MP0005386_behavior/neurological_phenoty | 0.90725792 |
| 87 | MP0004924_abnormal_behavior | 0.90725792 |
| 88 | MP0003861_abnormal_nervous_system | 0.90612035 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.90212374 |
| 90 | MP0002067_abnormal_sensory_capabilities | 0.89714223 |
| 91 | MP0004742_abnormal_vestibular_system | 0.88135831 |
| 92 | MP0002090_abnormal_vision | 0.88014471 |
| 93 | MP0001970_abnormal_pain_threshold | 0.86525471 |
| 94 | MP0000003_abnormal_adipose_tissue | 0.86311494 |
| 95 | MP0001963_abnormal_hearing_physiology | 0.83456250 |
| 96 | MP0001177_atelectasis | 0.82325377 |
| 97 | MP0001502_abnormal_circadian_rhythm | 0.82209237 |
| 98 | MP0003631_nervous_system_phenotype | 0.81916259 |
| 99 | MP0004510_myositis | 0.81880202 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.81747810 |
| 101 | MP0003011_delayed_dark_adaptation | 0.81217682 |
| 102 | MP0005076_abnormal_cell_differentiation | 0.78352233 |
| 103 | MP0009672_abnormal_birth_weight | 0.77590985 |
| 104 | MP0002557_abnormal_social/conspecific_i | 0.77471283 |
| 105 | MP0004885_abnormal_endolymph | 0.76383587 |
| 106 | MP0002971_abnormal_brown_adipose | 0.76289566 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.76226457 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.75666646 |
| 109 | MP0008260_abnormal_autophagy | 0.74787888 |
| 110 | MP0000579_abnormal_nail_morphology | 0.74741833 |
| 111 | MP0003787_abnormal_imprinting | 0.74352274 |
| 112 | MP0005551_abnormal_eye_electrophysiolog | 0.74313469 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.73198022 |
| 114 | MP0005670_abnormal_white_adipose | 0.72863481 |
| 115 | MP0002184_abnormal_innervation | 0.71091438 |
| 116 | MP0006276_abnormal_autonomic_nervous | 0.71044806 |
| 117 | MP0005646_abnormal_pituitary_gland | 0.70767286 |
| 118 | MP0000955_abnormal_spinal_cord | 0.70617820 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.70050586 |
| 120 | MP0001984_abnormal_olfaction | 0.70016440 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.68367810 |
| 122 | MP0005334_abnormal_fat_pad | 0.67953696 |
| 123 | MP0005166_decreased_susceptibility_to | 0.67518474 |
| 124 | MP0010769_abnormal_survival | 0.66788807 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.66642745 |
| 126 | MP0009764_decreased_sensitivity_to | 0.66351389 |
| 127 | MP0000598_abnormal_liver_morphology | 0.66138401 |
| 128 | MP0004142_abnormal_muscle_tone | 0.65834392 |
| 129 | MP0003953_abnormal_hormone_level | 0.65662018 |
| 130 | MP0005167_abnormal_blood-brain_barrier | 0.64765733 |
| 131 | MP0002229_neurodegeneration | 0.64389705 |
| 132 | MP0001943_abnormal_respiration | 0.64130861 |
| 133 | MP0005171_absent_coat_pigmentation | 0.63790608 |
| 134 | MP0006036_abnormal_mitochondrial_physio | 0.63642288 |
| 135 | MP0000537_abnormal_urethra_morphology | 0.63589462 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.63398346 |
| 137 | MP0010768_mortality/aging | 0.62872077 |
| 138 | MP0003172_abnormal_lysosome_physiology | 0.62553656 |
| 139 | MP0005636_abnormal_mineral_homeostasis | 0.61603166 |
| 140 | MP0005084_abnormal_gallbladder_morpholo | 0.61151477 |
| 141 | MP0001299_abnormal_eye_distance/ | 0.61063892 |
| 142 | MP0000747_muscle_weakness | 0.60644650 |
| 143 | MP0010770_preweaning_lethality | 0.60390232 |
| 144 | MP0002082_postnatal_lethality | 0.60390232 |
| 145 | MP0005410_abnormal_fertilization | 0.60237963 |
| 146 | MP0002752_abnormal_somatic_nervous | 0.59820385 |
| 147 | MP0002873_normal_phenotype | 0.59148482 |
| 148 | MP0002169_no_abnormal_phenotype | 0.58382376 |
| 149 | MP0003119_abnormal_digestive_system | 0.57964383 |
| 150 | MP0001731_abnormal_postnatal_growth | 0.57663252 |
| 151 | MP0002081_perinatal_lethality | 0.57191569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.70667686 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.62330511 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.99850385 |
| 4 | Xanthomatosis (HP:0000991) | 4.84052107 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.76099340 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.64705054 |
| 7 | Annular pancreas (HP:0001734) | 4.59419379 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.49790663 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.48479792 |
| 10 | Ankle clonus (HP:0011448) | 4.23837943 |
| 11 | Complement deficiency (HP:0004431) | 4.19107069 |
| 12 | Obstructive sleep apnea (HP:0002870) | 4.18483707 |
| 13 | Myokymia (HP:0002411) | 4.07822096 |
| 14 | Ketosis (HP:0001946) | 3.73808602 |
| 15 | Cerebral hypomyelination (HP:0006808) | 3.67459271 |
| 16 | Upper limb amyotrophy (HP:0009129) | 3.64172245 |
| 17 | Distal upper limb amyotrophy (HP:0007149) | 3.64172245 |
| 18 | Epidermoid cyst (HP:0200040) | 3.60908639 |
| 19 | Hyperammonemia (HP:0001987) | 3.59170836 |
| 20 | Insomnia (HP:0100785) | 3.56703546 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.54473298 |
| 22 | Hand muscle atrophy (HP:0009130) | 3.46741571 |
| 23 | Hyperglycinemia (HP:0002154) | 3.41886046 |
| 24 | Focal motor seizures (HP:0011153) | 3.30068883 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.28084673 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.26877474 |
| 27 | Hyperacusis (HP:0010780) | 3.26851671 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.25810309 |
| 29 | Spastic gait (HP:0002064) | 3.18623305 |
| 30 | Abnormality of the lower motor neuron (HP:0002366) | 3.18450204 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.15159297 |
| 32 | Joint hemorrhage (HP:0005261) | 3.13355473 |
| 33 | Visual hallucinations (HP:0002367) | 3.12365609 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.06981538 |
| 35 | Hyperglycinuria (HP:0003108) | 3.06032539 |
| 36 | Turricephaly (HP:0000262) | 3.02445379 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.98264144 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 2.98264144 |
| 39 | Diplopia (HP:0000651) | 2.96129207 |
| 40 | Abnormality of binocular vision (HP:0011514) | 2.96129207 |
| 41 | Status epilepticus (HP:0002133) | 2.94794773 |
| 42 | Ketoacidosis (HP:0001993) | 2.94010798 |
| 43 | Neuronal loss in central nervous system (HP:0002529) | 2.90331300 |
| 44 | Abnormality of complement system (HP:0005339) | 2.88921314 |
| 45 | Akinesia (HP:0002304) | 2.83043351 |
| 46 | Focal seizures (HP:0007359) | 2.81184223 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.79845701 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.78421231 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 2.75529904 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.72623951 |
| 51 | Truncal ataxia (HP:0002078) | 2.72173799 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.72120725 |
| 53 | Amblyopia (HP:0000646) | 2.69161206 |
| 54 | Ulnar bowing (HP:0003031) | 2.67429192 |
| 55 | Cholecystitis (HP:0001082) | 2.67413804 |
| 56 | Abnormal gallbladder physiology (HP:0012438) | 2.67413804 |
| 57 | Fat malabsorption (HP:0002630) | 2.66433282 |
| 58 | Delusions (HP:0000746) | 2.66316620 |
| 59 | Pointed chin (HP:0000307) | 2.63499146 |
| 60 | Gout (HP:0001997) | 2.62751546 |
| 61 | Neonatal onset (HP:0003623) | 2.62017073 |
| 62 | Peripheral hypomyelination (HP:0007182) | 2.57986977 |
| 63 | Spontaneous abortion (HP:0005268) | 2.56993155 |
| 64 | Atonic seizures (HP:0010819) | 2.56670802 |
| 65 | Torticollis (HP:0000473) | 2.55506965 |
| 66 | Impaired social interactions (HP:0000735) | 2.53923182 |
| 67 | Abnormal social behavior (HP:0012433) | 2.53923182 |
| 68 | Hyperbilirubinemia (HP:0002904) | 2.53573146 |
| 69 | Skin nodule (HP:0200036) | 2.52731427 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.52328805 |
| 71 | Conjugated hyperbilirubinemia (HP:0002908) | 2.51761431 |
| 72 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.51160721 |
| 73 | Lower limb amyotrophy (HP:0007210) | 2.47828316 |
| 74 | Febrile seizures (HP:0002373) | 2.47698097 |
| 75 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.47512569 |
| 76 | Action tremor (HP:0002345) | 2.46083237 |
| 77 | Sleep apnea (HP:0010535) | 2.44518694 |
| 78 | Focal dystonia (HP:0004373) | 2.43667693 |
| 79 | Bronchomalacia (HP:0002780) | 2.40672930 |
| 80 | Hyperventilation (HP:0002883) | 2.40607804 |
| 81 | Urinary urgency (HP:0000012) | 2.40246860 |
| 82 | Testicular atrophy (HP:0000029) | 2.40205458 |
| 83 | Cholelithiasis (HP:0001081) | 2.37119504 |
| 84 | Poor eye contact (HP:0000817) | 2.36418523 |
| 85 | Craniofacial dystonia (HP:0012179) | 2.35019032 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 2.34862662 |
| 87 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34254297 |
| 88 | Tetraplegia (HP:0002445) | 2.32004006 |
| 89 | Generalized tonic-clonic seizures (HP:0002069) | 2.30896522 |
| 90 | Long palpebral fissure (HP:0000637) | 2.29283148 |
| 91 | Apathy (HP:0000741) | 2.28259894 |
| 92 | Shallow orbits (HP:0000586) | 2.26868127 |
| 93 | Papilledema (HP:0001085) | 2.26608027 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.25808552 |
| 95 | Clonus (HP:0002169) | 2.24961648 |
| 96 | Absence seizures (HP:0002121) | 2.21069863 |
| 97 | Rapidly progressive (HP:0003678) | 2.19960528 |
| 98 | Progressive cerebellar ataxia (HP:0002073) | 2.19620307 |
| 99 | Stridor (HP:0010307) | 2.18473982 |
| 100 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17985258 |
| 101 | Epileptic encephalopathy (HP:0200134) | 2.17313382 |
| 102 | Amyloidosis (HP:0011034) | 2.15986649 |
| 103 | Mitral stenosis (HP:0001718) | 2.14825995 |
| 104 | Diminished motivation (HP:0000745) | 2.14820193 |
| 105 | Postural instability (HP:0002172) | 2.14768452 |
| 106 | Metabolic acidosis (HP:0001942) | 2.14607685 |
| 107 | Bradykinesia (HP:0002067) | 2.14488725 |
| 108 | Supranuclear gaze palsy (HP:0000605) | 2.14261337 |
| 109 | Irritability (HP:0000737) | 2.13204164 |
| 110 | Abnormality of serum amino acid levels (HP:0003112) | 2.12621017 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 2.12244134 |
| 112 | Achilles tendon contracture (HP:0001771) | 2.12122555 |
| 113 | Abnormality of purine metabolism (HP:0004352) | 2.11578789 |
| 114 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11578146 |
| 115 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.11576861 |
| 116 | Impaired smooth pursuit (HP:0007772) | 2.10553335 |
| 117 | Abnormality of the Achilles tendon (HP:0005109) | 2.09566647 |
| 118 | Broad distal phalanx of finger (HP:0009836) | 2.08619494 |
| 119 | Aplasia involving bones of the extremities (HP:0009825) | 2.08112081 |
| 120 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.08112081 |
| 121 | Aplasia of the phalanges of the hand (HP:0009802) | 2.08112081 |
| 122 | Neurofibrillary tangles (HP:0002185) | 2.08099174 |
| 123 | Dysdiadochokinesis (HP:0002075) | 2.06737798 |
| 124 | Rigidity (HP:0002063) | 2.05323451 |
| 125 | Hepatocellular carcinoma (HP:0001402) | 2.02615782 |
| 126 | Mutism (HP:0002300) | 2.01102976 |
| 127 | Dysmetric saccades (HP:0000641) | 2.00986987 |
| 128 | Systemic lupus erythematosus (HP:0002725) | 2.00760490 |
| 129 | Distal sensory impairment (HP:0002936) | 2.00369590 |
| 130 | Depression (HP:0000716) | 1.98583676 |
| 131 | Limb dystonia (HP:0002451) | 1.96232760 |
| 132 | CNS hypomyelination (HP:0003429) | 1.94843079 |
| 133 | Intention tremor (HP:0002080) | 1.93984322 |
| 134 | Choreoathetosis (HP:0001266) | 1.92431819 |
| 135 | Late onset (HP:0003584) | 1.92209550 |
| 136 | Dialeptic seizures (HP:0011146) | 1.91975015 |
| 137 | Anxiety (HP:0000739) | 1.91859223 |
| 138 | Spinal canal stenosis (HP:0003416) | 1.91840680 |
| 139 | Acanthocytosis (HP:0001927) | 1.91727830 |
| 140 | Stereotypic behavior (HP:0000733) | 1.90751412 |
| 141 | Hemiplegia (HP:0002301) | 1.90187557 |
| 142 | Truncus arteriosus (HP:0001660) | 1.89934214 |
| 143 | Hypoglycemic seizures (HP:0002173) | 1.89934162 |
| 144 | Myocardial infarction (HP:0001658) | 1.88301242 |
| 145 | Global brain atrophy (HP:0002283) | 1.87925084 |
| 146 | Elfin facies (HP:0004428) | 1.86824573 |
| 147 | Spastic diplegia (HP:0001264) | 1.86408408 |
| 148 | Abnormal eating behavior (HP:0100738) | 1.85569982 |
| 149 | Hyperthyroidism (HP:0000836) | 1.85558180 |
| 150 | Dysmetria (HP:0001310) | 1.85478610 |
| 151 | Abnormality of the gallbladder (HP:0005264) | 1.85249382 |
| 152 | Spastic tetraparesis (HP:0001285) | 1.84248167 |
| 153 | Lower limb asymmetry (HP:0100559) | 1.83962655 |
| 154 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83878373 |
| 155 | Hypsarrhythmia (HP:0002521) | 1.83679602 |
| 156 | Epileptiform EEG discharges (HP:0011182) | 1.83577840 |
| 157 | Scanning speech (HP:0002168) | 1.83247583 |
| 158 | Overriding aorta (HP:0002623) | 1.82864213 |
| 159 | Broad face (HP:0000283) | 1.81284855 |
| 160 | Distal lower limb amyotrophy (HP:0008944) | 1.81024505 |
| 161 | Abnormality of saccadic eye movements (HP:0000570) | 1.80645358 |
| 162 | Slow saccadic eye movements (HP:0000514) | 1.78684162 |
| 163 | Hammertoe (HP:0001765) | 1.78380867 |
| 164 | Lower limb muscle weakness (HP:0007340) | 1.77453531 |
| 165 | Growth hormone excess (HP:0000845) | 1.74848000 |
| 166 | Precocious puberty (HP:0000826) | 1.74531901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.63987423 |
| 2 | EPHA4 | 3.39004689 |
| 3 | DAPK2 | 3.29339971 |
| 4 | NTRK3 | 3.12257515 |
| 5 | MARK1 | 2.89840324 |
| 6 | MAP2K4 | 2.66205007 |
| 7 | MAP3K4 | 2.41335674 |
| 8 | KSR2 | 2.39547887 |
| 9 | BCKDK | 2.38521343 |
| 10 | MINK1 | 2.30844339 |
| 11 | PAK6 | 2.17584476 |
| 12 | TESK1 | 2.17256909 |
| 13 | CAMKK1 | 2.10432319 |
| 14 | ERN1 | 1.96208515 |
| 15 | FGFR4 | 1.81310856 |
| 16 | SMG1 | 1.73341796 |
| 17 | TRIB3 | 1.69588170 |
| 18 | PRKD3 | 1.67922180 |
| 19 | MAP2K7 | 1.67506201 |
| 20 | SIK1 | 1.65769388 |
| 21 | RIPK1 | 1.60993138 |
| 22 | NTRK2 | 1.53180308 |
| 23 | DAPK1 | 1.49814309 |
| 24 | SIK2 | 1.48544218 |
| 25 | TAOK1 | 1.48175390 |
| 26 | MAP3K13 | 1.47474074 |
| 27 | STK38 | 1.45756838 |
| 28 | EEF2K | 1.44787066 |
| 29 | NTRK1 | 1.41960367 |
| 30 | PKN2 | 1.34945196 |
| 31 | KSR1 | 1.33463938 |
| 32 | PINK1 | 1.31989211 |
| 33 | LATS2 | 1.29069663 |
| 34 | PRKCG | 1.23495942 |
| 35 | CDK5 | 1.18128961 |
| 36 | ARAF | 1.13760611 |
| 37 | BRSK1 | 1.13410244 |
| 38 | PHKG2 | 1.13128610 |
| 39 | PHKG1 | 1.13128610 |
| 40 | MAP3K7 | 1.09673153 |
| 41 | MAP3K2 | 1.09041123 |
| 42 | RET | 1.08472671 |
| 43 | GRK5 | 1.07947748 |
| 44 | BRAF | 1.05416436 |
| 45 | PRKCH | 1.01427386 |
| 46 | LIMK1 | 0.98232311 |
| 47 | CAMK2B | 0.98137835 |
| 48 | MAP3K12 | 0.97352761 |
| 49 | EPHA2 | 0.97276446 |
| 50 | PRKCZ | 0.91883041 |
| 51 | MST1R | 0.91819969 |
| 52 | SGK3 | 0.91649138 |
| 53 | NEK1 | 0.89850139 |
| 54 | IRAK2 | 0.89776670 |
| 55 | MAP3K1 | 0.88999880 |
| 56 | INSRR | 0.88230778 |
| 57 | RIPK4 | 0.88104685 |
| 58 | TYRO3 | 0.87749639 |
| 59 | PDK1 | 0.87702496 |
| 60 | CAMK1 | 0.86264044 |
| 61 | PDPK1 | 0.86161584 |
| 62 | NEK6 | 0.86122391 |
| 63 | IRAK3 | 0.83513953 |
| 64 | PRKD2 | 0.81363900 |
| 65 | PTK2 | 0.80549113 |
| 66 | PAK3 | 0.79776976 |
| 67 | ALK | 0.77682366 |
| 68 | LMTK2 | 0.75939291 |
| 69 | FES | 0.75635589 |
| 70 | CAMKK2 | 0.75189763 |
| 71 | TESK2 | 0.74993237 |
| 72 | MAPK12 | 0.74623808 |
| 73 | PRPF4B | 0.74447709 |
| 74 | STK11 | 0.74230429 |
| 75 | SGK223 | 0.72624200 |
| 76 | SGK494 | 0.72624200 |
| 77 | CAMK4 | 0.70885324 |
| 78 | ERBB4 | 0.70608282 |
| 79 | JAK2 | 0.70450333 |
| 80 | CAMK1G | 0.69950386 |
| 81 | MARK2 | 0.69842326 |
| 82 | RAF1 | 0.69129586 |
| 83 | SGK2 | 0.68338860 |
| 84 | MAPK11 | 0.66279515 |
| 85 | CDK12 | 0.65272972 |
| 86 | JAK1 | 0.63887890 |
| 87 | PRKG2 | 0.63022212 |
| 88 | MAPK10 | 0.62678720 |
| 89 | CAMK2A | 0.62042208 |
| 90 | MAP2K6 | 0.61399289 |
| 91 | BMX | 0.60718654 |
| 92 | CAMK2G | 0.60128705 |
| 93 | RPS6KA2 | 0.59065252 |
| 94 | TAOK3 | 0.58532529 |
| 95 | MAP2K1 | 0.58209230 |
| 96 | SIK3 | 0.57567453 |
| 97 | CDK19 | 0.57040675 |
| 98 | PRKACG | 0.56767854 |
| 99 | PLK2 | 0.56103232 |
| 100 | DAPK3 | 0.54583158 |
| 101 | CDK15 | 0.54104643 |
| 102 | ERBB2 | 0.52856015 |
| 103 | CSNK1G2 | 0.52707009 |
| 104 | CDK18 | 0.52440602 |
| 105 | TSSK6 | 0.51417735 |
| 106 | RPS6KA3 | 0.50477526 |
| 107 | PRKAA1 | 0.50337331 |
| 108 | PDGFRA | 0.50054211 |
| 109 | DYRK1B | 0.49975867 |
| 110 | ABL2 | 0.49016859 |
| 111 | PAK1 | 0.47881477 |
| 112 | ICK | 0.47814586 |
| 113 | PTK6 | 0.47687873 |
| 114 | SGK1 | 0.47444799 |
| 115 | MAP3K11 | 0.46891807 |
| 116 | AURKA | 0.46461179 |
| 117 | CDK14 | 0.46105900 |
| 118 | NME2 | 0.45412903 |
| 119 | DYRK1A | 0.45191111 |
| 120 | MTOR | 0.45075105 |
| 121 | PTK2B | 0.44677235 |
| 122 | CDK11A | 0.43089324 |
| 123 | TAOK2 | 0.42717850 |
| 124 | UHMK1 | 0.42372894 |
| 125 | GRK6 | 0.42247596 |
| 126 | MAP3K5 | 0.41064854 |
| 127 | TNK2 | 0.40911943 |
| 128 | PRKCI | 0.40548529 |
| 129 | PAK4 | 0.40039560 |
| 130 | MAPK13 | 0.39381842 |
| 131 | CAMK1D | 0.39247214 |
| 132 | FYN | 0.38840907 |
| 133 | MAPK8 | 0.37987159 |
| 134 | MAPK15 | 0.37268845 |
| 135 | PIM2 | 0.37041033 |
| 136 | MET | 0.33132079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.01798243 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.91433644 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.86004198 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.17870485 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48965954 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19909610 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16392278 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06968523 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06112277 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00388590 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.99976305 |
| 12 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.88370124 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83609392 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.82567970 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77907259 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.72673468 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72234433 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64131748 |
| 19 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.58905778 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50313099 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45236470 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.44818901 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.44391746 |
| 24 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.35363309 |
| 25 | Nicotine addiction_Homo sapiens_hsa05033 | 1.35010811 |
| 26 | Glioma_Homo sapiens_hsa05214 | 1.34996522 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32279992 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.31678413 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.28234035 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24226929 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22803179 |
| 32 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.22554627 |
| 33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21883524 |
| 34 | Melanogenesis_Homo sapiens_hsa04916 | 1.21160144 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21035406 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20838563 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20344505 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.20046780 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14248595 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13469377 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13319932 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12499854 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12470034 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11609760 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08840418 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07142178 |
| 47 | Gap junction_Homo sapiens_hsa04540 | 1.05628117 |
| 48 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.04470579 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.04190085 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04127624 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04125508 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02240922 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01058454 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00873247 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00631962 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00130052 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.99345041 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 0.96749882 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95893092 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.94472304 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.94439729 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93664116 |
| 63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.93076458 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92406741 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92337742 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92032835 |
| 67 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.91705527 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91173871 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.90712904 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90418490 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86383901 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85498273 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85048709 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.83079589 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82882961 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81002624 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80372730 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.79555365 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.79227822 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75504948 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74639199 |
| 82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74620780 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73508363 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.71280526 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71244538 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69074267 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67889412 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65685211 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65276604 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63348013 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.62973428 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62832373 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.61711719 |
| 94 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61700930 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60520320 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59680041 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59442808 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58970097 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58751697 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57782317 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57708981 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57211220 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56586635 |
| 104 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56275473 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55673117 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55566433 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54875363 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54177014 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53802948 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53623699 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.53263948 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53023854 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53012121 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52810734 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51714596 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50966916 |
| 117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50651914 |
| 118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49628913 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47989131 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46795344 |
| 121 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46309603 |
| 122 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45854702 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44901380 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44669860 |
| 125 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43842346 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43142948 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41575833 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41368922 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40619969 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.40484022 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39343518 |
| 132 | Renin secretion_Homo sapiens_hsa04924 | 0.39171531 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38294298 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.37606757 |
| 135 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.36994649 |
| 136 | Taste transduction_Homo sapiens_hsa04742 | 0.36278418 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36216361 |
| 138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36145163 |
| 139 | Alcoholism_Homo sapiens_hsa05034 | 0.35978786 |
| 140 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35461689 |
| 141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34977858 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34671877 |
| 143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34099776 |
| 144 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33383972 |
| 145 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32459527 |
| 146 | Long-term depression_Homo sapiens_hsa04730 | 0.30775449 |
| 147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30352447 |
| 148 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29539967 |

